DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company developing novel treatments for preeclampsia (PE), fetal growth restriction (FGR) and acute ischemic stroke (AIS) ...
AZ Animals

The Race to Understand Why the Fisher Population Is Declining

The fisher is a mammal that lives in the forest. This article explores how research is helping scientists protect this ...